A Medical-Grade TPU Portfolio Heads to Düsseldorf

ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade thermoplastic polyurethane (TPU), will exhibit at COMPAMED 2026, running November 16–19 at Messe Düsseldorf in Germany. The company will occupy Hall 8b, Booth C09, where it plans to showcase its TPU portfolio and introduce the newly formed Taiwan TPU Alliance.

The announcement positions the Hsinchu-based supplier squarely within the medical device materials supply chain, a segment where material performance, regulatory compliance and processing consistency carry outsized weight. COMPAMED, held alongside the larger medical technology trade fair in Düsseldorf, draws suppliers of components, materials and manufacturing systems — an audience well matched to ICP DAS-BMP's stated focus on medical-grade polymers.

Two Innovations in the Spotlight

The company said the spotlight will fall on two TPU innovations: the Low-Migration Series and the Low-Friction Series.

The Low-Migration Arothane™ ARP-B20 TPU complies with ISO 10993 and is suitable for implantation up to 90 days. According to ICP DAS-BMP, its formulation minimizes additive migration to the surface of medical devices, helping maintain long-term stability. Additive migration is a persistent concern in implantable and long-contact devices, where surface changes over time can affect both device performance and biocompatibility assessments.

The Low-Friction Series features an inherently smooth surface that eliminates the need for coatings or post-processing. Made entirely of TPU and free from PFAS and plasticizers, it is positioned to support improved comfort and control when handling invasive catheters with guidewires. The PFAS-free and plasticizer-free formulation speaks to a broader industry push toward material compositions that avoid substances facing increasing regulatory and environmental scrutiny.

A Structured Contact-Duration Framework

Beyond the two headline series, ICP DAS-BMP will present its ARP, ALP and ALC series support devices with Limited, Prolonged and Long-term contact durations under ISO 10993-1. The framework maps product families to the standard's contact-duration categories, giving device makers a structured way to match materials to intended use.

For radiopaque applications, the company's ARP/ALP/ALC-B20/B40 series contains 20–40% barium sulfate, while the ARP-W/WG series contains 40–60% tungsten to enhance visibility in invasive or implantable devices. Radiopacity — the ability of a material to appear under imaging — is a practical requirement for catheters and implants that clinicians must track during procedures.

The Engineering Arothane™ EARP series rounds out the portfolio, offering clarity and mechanical strength for orthodontic and precision components. Together, the lines span implantable, interventional, radiopaque and engineering applications, suggesting a strategy of covering multiple tiers of the medical device value chain rather than a single niche.

The Taiwan TPU Alliance Takes Shape

At COMPAMED 2026, ICP DAS-BMP will join the Taiwan TPU Alliance, initiated by Towards Buddha Co., Ltd., a manufacturer of TPU tubing. The Alliance brings together industry partners across the TPU and medical device manufacturing value chain:

  • INTYPE ENTERPRISE CO., LTD., a manufacturer of extrusion machinery
  • Chi Feng Co., Ltd., a manufacturer of injection molding components
  • A-MAX TECHNOLOGY CO., LTD., a supplier of auxiliary equipment for the rubber and plastics industry
  • ANEST IWATA SPARMAX Co., Ltd., a manufacturer of air compressors and vacuum pumps

The grouping connects expertise from medical-grade TPU materials and tubing through to injection molding, extrusion machinery, auxiliary equipment, and air and vacuum systems. For device manufacturers, the pitch is a coordinated supply chain rather than a set of disconnected vendors — an approach that can simplify qualification and reduce integration friction when scaling from prototype to production.

Industry Implications

The Alliance's formation reflects a wider pattern in medical device manufacturing, where material suppliers increasingly bundle processing know-how and equipment partnerships to serve customers who need validated, end-to-end solutions. For a mid-sized materials specialist such as ICP DAS-BMP, aligning with tubing, molding and machinery partners can extend its reach into device programs that would otherwise require assembling multiple suppliers independently.

The emphasis on low-migration formulations, PFAS-free compositions and ISO 10993 alignment also tracks the regulatory direction of travel. Device makers are under pressure to document long-term material stability and to anticipate restrictions on certain chemical classes, making supplier claims about migration behavior and additive content commercially relevant.

Company Background

ICP DAS-BMP describes itself as a leading TPU manufacturer and supplier based in Taiwan. It is ISO 13485 certified and operates laboratories focused on quality management. The company draws on over thirty years of industrial automation expertise from its parent company, ICP DAS, and says it uses smart factory practices to enhance product quality and shorten delivery times. It also cites responsive after-sales support and flexible solutions, even for small order quantities, as elements of its customer proposition.

Whether the Alliance and the new series translate into design wins will depend on qualification cycles that typically run long in medical devices. COMPAMED 2026 will serve as the company's venue for making that case to device engineers and procurement teams in person.